Boston Bio Systems Ltd.
BSE: 531458
₹5.70
₹-0.29
(-4.84%)
As on 24-Jun-2026IST
Market cap
₹4 Cr
Revenue (TTM)
₹0 Cr
P/E Ratio
--
P/B Ratio
-3.1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-7 Cr
-
ROE
-8.9 %
-
ROCE
-5.9 %
-
Industry P/E
25
-
EV/EBITDA
-0.8
-
Debt to Equity
0
-
Book Value
₹--
-
EPS
₹-10.2
-
Face value
10
-
Shares outstanding
7,002,200
10 Years Aggregate
CFO
₹-4.52 Cr
EBITDA
₹-0.69 Cr
Net Profit
₹-0.69 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Boston Bio Systems
| -21.6 | -26.0 | -31.4 | -31.2 | -- | -- | -- |
|
BSE Finance*
| -3.6 | 5.5 | 9.9 | -0.4 | 11.0 | 10.2 | 12.6 |
|
Company
|
2014
|
|---|---|
|
Boston Bio Systems
| 248.1 |
|
BSE Small Cap
| 69.2 |
|
BSE Finance
| 59.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Boston Bio Systems
|
5.7 | 4.0 | 0.5 | -7.2 | -1,360.3 | -- | -- | -3.1 |
| 329.3 | 1,575.1 | 179.4 | 64.8 | 27.4 | 5.3 | 25 | 1.0 | |
| 541.2 | 3,413.2 | 932.2 | 129.3 | 37.8 | 14.1 | 26.4 | 2.6 | |
| 335.3 | 30,610.9 | 5,136.6 | 915.1 | 33.0 | 16.1 | 33.5 | 5.2 | |
| 723.9 | 16,149.1 | 1,118.4 | 237.9 | 33.9 | 15.9 | 74.2 | 9.9 | |
| 79.3 | 2,204.0 | 671.1 | 79.4 | 18.2 | 7.4 | 27.4 | 1.8 | |
| 91.1 | 1,634.9 | 1,855.5 | 181.6 | 83.6 | 10.8 | 9 | 1.0 | |
| 2,988.7 | 12,351.2 | 1,317.3 | 222.1 | 21.2 | 27 | 55.6 | 14.0 | |
| 135.2 | 2,955.2 | 1,470.3 | 324.4 | 37.6 | 12.6 | 9.1 | 1.1 | |
| 72.3 | 1,514.4 | 1,876.9 | 103.3 | 18.6 | 8.2 | 14.8 | 1.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Boston Bio Systems
Security and commodity contracts brokerage
-
Incorporated
1995
-
Chairman
--
-
Managing Director
Ghanshyam Dhananjay Gavali
-
Headquarters
Ahmedabad, Gujarat
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Boston Bio Systems
What is the current share price of Boston Bio Systems Ltd Today?
The share price of Boston Bio Systems Ltd is ₹5.70 (BSE) as of 24-Jun-2026 IST. Boston Bio Systems Ltd has given a return of -31.16% in the last 1 years.
What is the current PB & PE ratio of Boston Bio Systems Ltd?
Since, TTM earnings of Boston Bio Systems Ltd is negative, P/E ratio is not available.
The P/B ratio of Boston Bio Systems Ltd is -3.14 times as on 24-Jun-2026, a 218 discount to its peers’ median range of 2.65 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.92
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
What is the 52 Week High and Low of Boston Bio Systems Ltd?
The 52-week high and low of Boston Bio Systems Ltd are Rs 10.95 and Rs 5.13 as of 26-Jun-2026.
What is the market cap of Boston Bio Systems Ltd?
Boston Bio Systems Ltd has a market capitalisation of ₹ 4 Cr as on 24-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Boston Bio Systems Ltd?
Before investing in Boston Bio Systems Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.